These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 27378567)

  • 41. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats.
    Reinke Y; Gross S; Eckerle LG; Hertrich I; Busch M; Busch R; Riad A; Rauch BH; Stasch JP; Dörr M; Felix SB
    Eur J Pharmacol; 2015 Nov; 767():1-9. PubMed ID: 26407652
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Redox regulation of soluble guanylyl cyclase.
    Shah RC; Sanker S; Wood KC; Durgin BG; Straub AC
    Nitric Oxide; 2018 Jun; 76():97-104. PubMed ID: 29578056
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nitric Oxide-Independent Soluble Guanylate Cyclase Activation Improves Vascular Function and Cardiac Remodeling in Sickle Cell Disease.
    Potoka KP; Wood KC; Baust JJ; Bueno M; Hahn SA; Vanderpool RR; Bachman T; Mallampalli GM; Osei-Hwedieh DO; Schrott V; Sun B; Bullock GC; Becker-Pelster EM; Wittwer M; Stampfuss J; Mathar I; Stasch JP; Truebel H; Sandner P; Mora AL; Straub AC; Gladwin MT
    Am J Respir Cell Mol Biol; 2018 May; 58(5):636-647. PubMed ID: 29268036
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gaseous transmitter regulation of hypoxia-evoked catecholamine secretion from murine adrenal chromaffin cells.
    Gridina A; Su X; Khan SA; Peng YJ; Wang B; Nanduri J; Fox AP; Prabhakar NR
    J Neurophysiol; 2021 May; 125(5):1533-1542. PubMed ID: 33729866
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Different regulatory effects of hydrogen sulfide and nitric oxide on gastric motility in mice.
    Huang X; Meng XM; Liu DH; Wu YS; Guo X; Lu HL; Zhuang XY; Kim YC; Xu WX
    Eur J Pharmacol; 2013 Nov; 720(1-3):276-85. PubMed ID: 24157974
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cobinamides are novel coactivators of nitric oxide receptor that target soluble guanylyl cyclase catalytic domain.
    Sharina I; Sobolevsky M; Doursout MF; Gryko D; Martin E
    J Pharmacol Exp Ther; 2012 Mar; 340(3):723-32. PubMed ID: 22171090
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation.
    Nimmegeers S; Sips P; Buys E; Brouckaert P; Van de Voorde J
    Cardiovasc Res; 2007 Oct; 76(1):149-59. PubMed ID: 17610859
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels.
    Stasch JP; Schmidt PM; Nedvetsky PI; Nedvetskaya TY; H S AK; Meurer S; Deile M; Taye A; Knorr A; Lapp H; Müller H; Turgay Y; Rothkegel C; Tersteegen A; Kemp-Harper B; Müller-Esterl W; Schmidt HH
    J Clin Invest; 2006 Sep; 116(9):2552-61. PubMed ID: 16955146
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
    Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R
    Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Volume overload induces differential spatiotemporal regulation of myocardial soluble guanylyl cyclase in eccentric hypertrophy and heart failure.
    Liu Y; Dillon AR; Tillson M; Makarewich C; Nguyen V; Dell'Italia L; Sabri AK; Rizzo V; Tsai EJ
    J Mol Cell Cardiol; 2013 Jul; 60():72-83. PubMed ID: 23567617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative Studies of the Dynamics Effects of BAY60-2770 and BAY58-2667 Binding with Human and Bacterial H-NOX Domains.
    Rehan Khalid R; Tahir Ul Qamar M; Maryam A; Ashique A; Anwar F; H Geesi M; Siddiqi AR
    Molecules; 2018 Aug; 23(9):. PubMed ID: 30149624
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse.
    Zhu G; Groneberg D; Sikka G; Hori D; Ranek MJ; Nakamura T; Takimoto E; Paolocci N; Berkowitz DE; Friebe A; Kass DA
    Hypertension; 2015 Feb; 65(2):385-92. PubMed ID: 25452469
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The soluble guanylyl cyclase activator BAY 60-2770 inhibits murine allergic airways inflammation and human eosinophil chemotaxis.
    Baldissera L; Squebola-Cola DM; Calixto MC; Lima-Barbosa AP; Rennó AL; Anhê GF; Condino-Neto A; De Nucci G; Antunes E
    Pulm Pharmacol Ther; 2016 Dec; 41():86-95. PubMed ID: 27816773
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nitric oxide-independent down-regulation of soluble guanylyl cyclase by bacterial endotoxin in astroglial cells.
    Baltrons MA; García A
    J Neurochem; 1999 Nov; 73(5):2149-57. PubMed ID: 10537075
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel soluble guanylyl cyclase activator, BR 11257, acts as a non-stabilising partial agonist of sGC.
    Elgert C; Rühle A; Sandner P; Behrends S
    Biochem Pharmacol; 2019 May; 163():142-153. PubMed ID: 30753814
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prolonged NO treatment decreases alpha-adrenoreceptor agonist responsiveness in porcine pulmonary artery due to persistent soluble guanylyl cyclase activation.
    Perkins WJ; Kost S; Danielson M
    Am J Physiol Lung Cell Mol Physiol; 2009 Apr; 296(4):L666-73. PubMed ID: 19181745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: role of hydrogen sulfide.
    Salloum FN; Das A; Samidurai A; Hoke NN; Chau VQ; Ockaili RA; Stasch JP; Kukreja RC
    Am J Physiol Heart Circ Physiol; 2012 Mar; 302(6):H1347-54. PubMed ID: 22268103
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel Angiogenic Activity and Molecular Mechanisms of ZYZ-803, a Slow-Releasing Hydrogen Sulfide-Nitric Oxide Hybrid Molecule.
    Hu Q; Wu D; Ma F; Yang S; Tan B; Xin H; Gu X; Chen X; Chen S; Mao Y; Zhu YZ
    Antioxid Redox Signal; 2016 Sep; 25(8):498-514. PubMed ID: 27174595
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Potential of sGC Modulators for the Treatment of Age-Related Fibrosis: A Mini-Review.
    Sandner P; Berger P; Zenzmaier C
    Gerontology; 2017; 63(3):216-227. PubMed ID: 27784018
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
    Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
    Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.